𝔖 Bobbio Scriptorium
✦   LIBER   ✦

MGMT promoter hypermethylation correlates with a survival benefit from temozolomide in patients with recurrent anaplastic astrocytoma but not glioblastoma

✍ Scribed by J. Sadones; A. Michotte; P. Veld; C. Chaskis; R. Sciot; J. Menten; E.J.R. Joossens; T. Strauven; L.A. D’Hondt; D. Sartenaer; S.F.E.H. Califice; K. Bierau; C. Svensson; J. De Grève; B. Neyns


Book ID
116429799
Publisher
Elsevier Science
Year
2009
Tongue
English
Weight
153 KB
Volume
45
Category
Article
ISSN
0959-8049

No coin nor oath required. For personal study only.